Menu
Back to Journals » Infection and Drug Resistance » Volume 14
Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales [Corrigendum]
Authors Tan X, Kim HS, Baugh K, Huang Y, Kadiyala N, Wences M, Singh N, Wenzler E, Bulman ZP
Received 10 February 2021
Accepted for publication 10 February 2021
Published 16 February 2021 Volume 2021:14 Pages 595—596
Tan X, Kim HS, Baugh K, et al. Infect Drug Resist.2021;14:125–142.
Page 134, left column, second paragraph, fourth sentence from the bottom, the text “Generally, all four tetracyclines have higher tissue concentrations than serum, concentration- dependent plasma protein binding ranging from 70% to 90% (except eravacycline is 21%), and exhibit minimal renal clearance” should read “Generally, all four tetracyclines have higher tissue concentrations than serum, concentration- dependent plasma protein binding ranging from 70% to 90% (except omadacycline is 21%), and exhibit minimal renal clearance”.
The authors apologize for this error.
Read the original article
Tan X, Kim HS, Baugh K, et al. Infect Drug Resist. 2021;14:125–142.
Page 134, left column, second paragraph, fourth sentence from the bottom, the text “Generally, all four tetracyclines have higher tissue concentrations than serum, concentration-dependent plasma protein binding ranging from 70% to 90% (except eravacycline is 21%), and exhibit minimal renal clearance” should read “Generally, all four tetracyclines have higher tissue concentrations than serum, concentration-dependent plasma protein binding ranging from 70% to 90% (except omadacycline is 21%), and exhibit minimal renal clearance”.
The authors apologize for this error.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.